Several studies have been published recently reporting a link between exposure to per- and polyfluoroalkyl substances (PFAS) and metabolic-associated fatty liver disease (MAFLD, a proposed alternative to non-alcoholic fatty liver disease). Notably, MAFLD is growing rapidly, with an estimated prevalence of 100 million people affected in the U.S. alone by 2030, about 1/3 of the…